Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?
Jill P. Buyon(New York University), Bevra H. Hahn(University of California, Los Angeles), Joan T. Merrill(Oklahoma Medical Research Foundation), Christianne Yung(University of California, Los Angeles), H. Michael Belmont(New York University), Lisa R. Sammaritano(Hospital for Special Surgery), Michelle Petri(Johns Hopkins University), Mary Louise Skovron(New York University Langone Orthopedic Hospital), Kenneth Kalunian(University of California, San Diego), Robert G. Lahita(St. Luke's-Roosevelt Hospital Center), Frederick Licciardi(Bellevue Hospital Center)
Cited by 57
Related Papers
Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management.
|PubMed|1995|1.9k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748